Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label follow-up study of telmisartan + amlodipine fixed-dose combinations in hypertension
2007-002422-29Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of telmisartan and amlodipine in essential hypertension (2 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Proportion of patients achieving diastolic blood pressure control. Started Sep 2007; status: completed.
02
Drugs
telmisartanamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2007-002422-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002422-29.